Effects of burosumab treatment on mineral homeostasis in children and adolescents with X-linked hypophosphatemia: lessons from the German XLH Registry

被引：0
|
作者：
Ewert, Annika [1 ]
Rehberg, Mirko [2 ]
Schlingmann, Karl Peter [3 ]
Kemper, Markus [4 ]
Patzer, Ludwig [5 ]
John, Ulrike [6 ]
Metzing, Oliver [6 ]
Staude, Hagen [7 ]
Weitz, Marcus [8 ]
Wuehl, Elke [9 ,10 ]
Schaefer, Franz [9 ,10 ]
Freiberg, Clemens [11 ]
Hiort, Olaf [12 ]
Schnabel, Dirk [13 ]
Haffner, Dieter [1 ]
机构：
[1] Hannover Med Sch, Dept Pediat Nephrol, Hannover, Germany
[2] Univ Cologne, Dept Pediat, Cologne, Germany
[3] Univ Childrens Hosp, Dept Gen Pediat Pediat Nephrol, Munster, Germany
[4] Asklepios Childrens Hosp Hamburg Heidberg, Pediat, Hamburg, Germany
[5] St Elisabeth & St Barbara Childrens Hosp, Pediat, Halle, Germany
[6] Univ Childrens Hosp, Pediat Nephrol, Jena, Germany
[7] Univ Childrens Hosp, Pediat Nephrol, Rostock, Germany
[8] Univ Childrens Hosp, Pediat Nephrol, Tubingen, Germany
[9] Univ Heidelberg Hosp, Div Pediat Nephrol, Heidelberg, Germany
[10] Ctr Pediat & Adolescent Med, Heidelberg, Germany
[11] Univ Med Gottingen, Dept Pediat, Gottingen, Germany
[12] Univ Childrens Hosp Lubeck, Pediat, Lubeck, Germany
[13] Univ Med Charite, Ctr Chronically Sick Children Pediat Endocrinol, Berlin, Germany
来源：
PEDIATRIC NEPHROLOGY | 2023年 / 38卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
O-19
引用
收藏
页码：2264 / 2265
页数：2
相关论文
共 50 条
  • [41] Real-world data of Brazilian adults with X-linked hypophosphatemia (XLH) treated with burosumab and comparison with other worldwide cohorts
    Vaisbich, Maria Helena
    de Cillo, Antonio Cesar Paulillo
    Silva, Barbara Campolina C.
    Dalva, Catarina Brasil
    de Carvalho, Erico Higino
    de Almeida, Juliana M. C. M.
    Marques, Larissa L. M.
    Ribeiro, Marcia
    da Silva, Mauro Borghi M.
    de Medeiros, Paula Frassinetti V.
    Mendes, Pedro Henrique
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2024, 12 (02):
  • [42] Effectiveness of Burosumab Versus Conventional Therapy in Adults With X-Linked Hypophosphatemia in a Real-World Setting From the XLH Disease Monitoring Program
    Florenzano, Pablo
    Imel, Erik A.
    Khan, Aliya Aziz
    Johnson, Ben
    Vincent, Marc
    Nomura, Takanobu
    Krolczyk, Stanley
    Li, Zhiyi
    Ward, Leanne M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 172 - 172
  • [43] X-LINKED HYPOPHOSPHATEMIA (XLH) - ABSENCE OF GENDER AND MODE-OF-GENETIC-TRANSMISSION EFFECTS ON DISEASE EXPRESSION IN CHILDREN
    ARMAMENTOVILLAREAL, R
    SCHRANCK, F
    WHYTE, MP
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 : S292 - S292
  • [44] The effects of burosumab on growth, nephrocalcinosis and cardiovascular outcomes in children with X-linked hypophosphatemia: a single-center experience
    Bettyna Olivotto
    Eliane Djatougbé Akolly
    Sara Cabet
    Sacha Flammier
    Aurélia Bertholet-Thomas
    Aurélie de Mul
    Justine Bacchetta
    Journal of Rare Diseases, 3 (1):
  • [45] Health-related Quality of Life of Children with X-linked Hypophosphatemia in Germany in the Burosumab Era
    Boeckmann, Ineke
    Klein, Martin
    Obermaier, Michael
    Mutze, Helena
    Wilden, Sophia
    Rehberg, Mirko
    Schlingmann, Karl
    Metzing, Oliver
    Kemper, Markus
    Weitz, Marcus
    Wuehl, Elke
    Patzer, Ludwig
    Zivicnjak, Miroslav
    Schnabel, Dirk
    Haffner, Dieter
    PEDIATRIC NEPHROLOGY, 2024, 39 (01) : S266 - S266
  • [46] Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia
    Ward, Leanne M.
    Glorieux, Francis H.
    Whyte, Michael P.
    Munns, Craig F.
    Portale, Anthony A.
    Hoegler, Wolfgang
    Simmons, Jill H.
    Gottesman, Gary S.
    Padidela, Raja
    Namba, Noriyuki
    Cheong, Hae Il
    Nilsson, Ola
    Mao, Meng
    Chen, Angel
    Skrinar, Alison
    Roberts, Mary Scott
    Imel, Erik A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (08): : E3241 - E3253
  • [47] Newly Diagnosed Hyperparathyroidism After 3 Years Of Burosumab In Children Affected With X-Linked Hypophosphatemia
    Zhukouskaya, Volha
    Ertl, Alexandra
    Berkenou, Jugurtha
    Audrain, Christelle
    Bardet, Claire
    Chaussain, Catherine
    Rothenbuhler, Anya
    Linglart, Agnes
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 433 - 433
  • [48] Combined Treatment With Leuprolide Acetate and Burosumab in X-linked Hypophosphatemia and Precocious Puberty: A Therapeutic Response
    Penna, Gustavo Tempone Cardoso
    Figueiredo, Carolina Costa
    Evangelista, Nara Michelle de Araujo
    Fernandes, Vania de Fatima Tonetto
    Salmona, Patricia
    Neto, Guido de Paula Colares
    AACE CLINICAL CASE REPORTS, 2025, 11 (01): : 18 - 23
  • [49] High bone mineral apparent density in children with X-linked hypophosphatemia
    Beck-Nielsen, S. S.
    Brixen, K.
    Gram, J.
    Molgaard, C.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (08) : 2215 - 2221
  • [50] Burosumab Improved Rickets, Phosphate Metabolism, and Clinical Outcomes Compared to Conventional Therapy in Children with X-Linked Hypophosphatemia (XLH) - A Randomized Controlled Phase 3 Study
    Nilsson, Ola
    Whyte, Michael P.
    Imel, Erik A.
    Munns, Craig
    Portale, Anthony A.
    Ward, Leanne
    Simmons, Jill H.
    Padidela, Raja
    Namba, Noriyuki
    Cheong, Hae Il
    Mao, Meng
    Skrinar, Alison
    Chen, Chao-Yin
    Martin, Javier San
    Glorieux, Francis
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 57 - 58
12345